National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

Found 40 cases where Location is Texas and Vaccine is HPV or HPV2 or HPV4 and Disabled

Table

   
AgeSexCountPercent
9-12 YearsFemale25%
total25%
12-17 YearsMale12.5%
Female2255%
total2357.5%
17-44 YearsFemale1230%
total1230%
UnknownFemale37.5%
total37.5%
TOTAL40100%

Case Details

This is page 1 out of 4

Result pages: 1 2 3 4   next


VAERS ID: 286564 (history)  
Form: Version 1.0  
Age: 11.0  
Sex: Female  
Location: Texas  
Vaccinated:2007-07-05
Onset:2007-07-13
   Days after vaccination:8
Submitted: 2007-08-02
   Days after onset:20
Entered: 2007-08-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPA: HEP A (VAQTA) / MERCK & CO. INC. 0246U / 2 RA / IM
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0802U / 1 LA / IM
VARCEL: VARICELLA (VARIVAX) / MERCK & CO. INC. 0535U / 2 RA / SC

Administered by: Unknown       Purchased by: Unknown
Symptoms: Blood glucose increased, Diabetes mellitus insulin-dependent
SMQs:, Hyperglycaemia/new onset diabetes mellitus (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: glucose - 977 records received 8/30/07-WBC 10.5. Segs 85. Postassium 5.6. carbon dioxide 18.9. Anion Gap of 33, Phosporus 6.6. osmolality of 322. Blood sugar greater than 900.
CDC Split Type:

Write-up: Came to office 1 week after immunizations were given with New onset Type 1 DM with sugar of 977. 8/30/07-records received-for DOS 7/13-7/15/07- DC DX: Diabetic ketoacidosis resolved. Type I diabetes new onset. Dehydration resolved. Hyperkalemia, resolved. Two week history of polyuria, polydipsia, nocturia, dry mouth and blurry vision, 12 pound weight loss for the last month or so. in ED blood sugar over 1000. C/O not feeling well, weak, decreased appetite, nausea and vomiting. 1/11/2010 Patient has type I DM.


VAERS ID: 288458 (history)  
Form: Version 1.0  
Age: 19.0  
Sex: Female  
Location: Texas  
Vaccinated:2007-08-06
Onset:2007-08-06
   Days after vaccination:0
Submitted: 2007-08-17
   Days after onset:11
Entered: 2007-08-20
   Days after submission:3
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0929U / 1 UN / IM

Administered by: Other       Purchased by: Other
Symptoms: Abdominal pain, Blood thyroid stimulating hormone normal, Diarrhoea, Full blood count normal, Nausea, Vomiting
SMQs:, Acute pancreatitis (broad), Retroperitoneal fibrosis (broad), Pseudomembranous colitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Noninfectious diarrhoea (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: OVCON
Current Illness:
Preexisting Conditions: Cholecystectomy
Allergies:
Diagnostic Lab Data: complete blood cell 08/07/07 normal; serum TSH 08/07/07 normal
CDC Split Type: WAES0708USA01429

Write-up: Information has been received from a registered nurse concerning a 19 year old female patient with a history of cholecystectomy (FEBRUARY 2005) and no allergies who on 06-AUG-2007, was vaccinated IM with a first 0.5ml dose of Gardasil (Lot # 658282/0929U). Concomitant therapy included ethinyl estradiol/norethidrone (OVCON). About 2 hours after receiving the vaccine, the patient experienced severe abdominal pain, nausea, vomiting and diarrhea. The patient stated that the area that hurts was about 2 inches from her belly button. The patient was prescribed atropine sulfate (+) diphenoxylate hydrochloride (LOMOTRIL) and promethazine hydrochloride (PHENERGAN). It was reported that the next day the patient called the office and her stomach pain had gotten worse. On a scale of 1 to 10 the patient felt her pain was a six. Laboratory diagnostic studies given on 07-AUG-2007 included a CBC and a thyroid study. Both were reported as normal. The patient no longer has diarrhea but was still experiencing nausea and vomiting. The outcome of severe abdominal pain was unknown. No product quality complaint was involved. Severe abdominal pain, nausea, vomiting and diarrhea were considered to be disabling. Additional information has been requested.


VAERS ID: 312479 (history)  
Form: Version 1.0  
Age: 19.0  
Sex: Female  
Location: Texas  
Vaccinated:2008-04-04
Onset:2008-05-01
   Days after vaccination:27
Submitted: 2008-05-16
   Days after onset:15
Entered: 2008-05-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0525U / 3 UN / UN

Administered by: Unknown       Purchased by: Unknown
Symptoms: Acute myeloid leukaemia, Biopsy bone marrow abnormal, Hepatic enzyme increased, Malaise, Nausea, Pancytopenia, Vomiting, Weight decreased
SMQs:, Liver related investigations, signs and symptoms (narrow), Acute pancreatitis (broad), Agranulocytosis (narrow), Haematopoietic cytopenias affecting more than one type of blood cell (narrow), Hyperglycaemia/new onset diabetes mellitus (broad), Malignancy related therapeutic and diagnostic procedures (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Malignant lymphomas (broad), Myelodysplastic syndrome (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Haematological malignant tumours (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 24 days
   Extended hospital stay? Yes
Previous Vaccinations: none~ ()~~0.00~In Patient|none~ ()~~0.00~In Sibling
Other Medications: none
Current Illness: none
Preexisting Conditions: none. PMH: none
Allergies:
Diagnostic Lab Data: pancytopenia, increased liver enzymes; bone marrow biopsy on 5-5-08 showed acute myelogenous leukemia;Gardasil series: 9-26-07, 11-21-07 & 4-4-08 (#13does not allow Gardasil to be entered). Labs and Diagnostics: Urine dipstick orange with small bili, 15 ketones, protein 100, urobilinogen 4. Rapid strep (-). Total bili 2.0. CBC with WBC 3.1, RBC 2.4, Hgb 7.8, Hct 25.1, platelets 69. MCV high at 104.7 and nucleated RBCs 8/100. Hep profile all (-)( Hep A IgM, Hep B core IgM, Hep B surf AG, Hep C antibody). Labs and Diagnostics: CBC on admission with WBC 3.0, RBC 3.26, Hgb 10.6, Hct 29.7, platelets 60K. WBC dropped to a low of 0.3 recovering to 8.2 by d/c. platelets peaked at 110K, down to 36K by d/c. RBC, Hct, and Hgb remained at admission levels throughout admission. LFTs elevated. Vit B12$g1500. HLA testing done. Blood cx (-). Sputum (+) for yeast. Stool (+) for occult blood. NPM1 gene mutation (+). CT abd & pelvis (+) for pancolitis and prominent retroperitoneal lymph nodes. Repeat (+) for ascites. head CT with paranasal sinus mucosal thickening. MUGA scan WNL. LUE Dopplar (+) for patially occlusive thrombus, no DVT on R. Pelvic sono (+) for bladder distention. Abd sono (+) for biliary duct dilitation.
CDC Split Type:

Write-up: weight loss, nausea & vomiting, malaise. 5/20/08 Office records received including vax record. Seen for sick visit 5/01/08 with c/o nausea, vomiting, and stomach feeling whoozy x 1 month. Impression Nausea & Vomiting. Tx with metoclopramide. Seen again 5/5/08 with c/o sore throat, nausea, back pain. Impression: N&V, Bilirubinuria, pancytopenia. Referral made to Oncologist. 07/01/2008 MR received for DOS 05/7-31/2008 with D/C DX: Acute Myeloid Leukemia. Pt presented with pancytopenia for eval to r/o acute leukemia. Bone marrow bx confirmed AML. Started on chemo which initially was well tolerated but later developed severe abdominal c/o with hematochezia. DX with pancolitis, likely infectious. Pt had intermittent high fevers and hypotension. Pt developed a clot in her PICC line and it was removed. Blood counts somewhat recovered and pt d/c 5/31/08.


VAERS ID: 318289 (history)  
Form: Version 1.0  
Age: 21.0  
Sex: Female  
Location: Texas  
Vaccinated:2008-05-06
Onset:0000-00-00
Submitted: 2008-07-03
Entered: 2008-07-07
   Days after submission:4
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 2 UN / IM

Administered by: Other       Purchased by: Other
Symptoms: Impaired work ability, Injected limb mobility decreased, Pain in extremity
SMQs:, Tendinopathies and ligament disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: Unknown
CDC Split Type: WAES0806USA08616

Write-up: Information has been received from a physician concerning a 21 year old female who on an unspecified date was vaccinated with a first dose of GARDASIL. On 06-MAY-2008 the patient was vaccinated IM into the deltoid with a second 0.5ml dose of GARDASIL. The patient developed unspecified arm pain at an unspecified time after the injection and inability to raise the arm above the shoulder level which caused her disability from her work. The patient sought treatment with a chiropractor. At the time of the report the patient was not recovered. The physician considered the unspecified arm pain and inability to raise the arm above the shoulder level to be disabling. Additional information has been requested.


VAERS ID: 319289 (history)  
Form: Version 1.0  
Age:   
Sex: Female  
Location: Texas  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2008-07-15
Entered: 2008-07-16
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / IM

Administered by: Other       Purchased by: Other
Symptoms: Paralysis
SMQs:, Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Surgical procedure
Allergies:
Diagnostic Lab Data: Unknown
CDC Split Type: WAES0807USA01601

Write-up: Information has been received from a physician concerning a female with a history of dental procedure in which paralysis occurred who was vaccinated with GARDASIL IM. The patient developed paralysis after vaccination. The patient was considered to be disabling. The patient sought medical attention. Additional information has been requested.


VAERS ID: 320560 (history)  
Form: Version 1.0  
Age: 17.0  
Sex: Female  
Location: Texas  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2008-07-25
Entered: 2008-07-28
   Days after submission:3
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 2 UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Skin laceration, Syncope
SMQs:, Torsade de pointes/QT prolongation (broad), Arrhythmia related investigations, signs and symptoms (broad), Accidents and injuries (narrow), Hostility/aggression (broad), Cardiomyopathy (broad), Hypotonic-hyporesponsive episode (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: Unknown
CDC Split Type: WAES0807USA04414

Write-up: Information has been received from a physician concerning a 17 year old female on an unknown date was vaccinated with the second dose of GARDASIL. After getting the second dose, the patient fainted and hit her head (causing a gash on her head). The patient sought medical attention. The patient''s outcome was not reported. Patient fainted and hit her head (causing a gash on her head) were considered to be disabling by the reporting physician. Additional information has been requested.


VAERS ID: 321133 (history)  
Form: Version 1.0  
Age: 13.0  
Sex: Female  
Location: Texas  
Vaccinated:2008-03-05
Onset:2008-03-05
   Days after vaccination:0
Submitted: 2008-08-01
   Days after onset:148
Entered: 2008-08-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0052X / 2 LA / IM

Administered by: Private       Purchased by: Private
Symptoms: Immediate post-injection reaction, Injection site atrophy, Injection site pain, Muscle atrophy
SMQs:, Peripheral neuropathy (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Extravasation events (injections, infusions and implants) (broad), Hypersensitivity (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: YAZ; Claritin; Adderall; Kenalog
Current Illness:
Preexisting Conditions: NKDA; Seasonal allergies
Allergies:
Diagnostic Lab Data: None
CDC Split Type:

Write-up: Muscle/tissue atrophy at injection site almost immediately apparent - after 5 months approximately has not resolved. Patient had Kenalog injection 2 days prior at another injection site. This is in follow-up report(s) previously submitted on 9/15/2008. Intial and follow-up inforamtion has been recieved froma a nurse practitioner concerning a 11 year old female with no pertinent medical history or history of drug reactions or drug allergies who on 30-OCT-2007 was vaccinated witht he first does of GRADASIL. On aaproximately 03-MAR-2008, "two days prior to" the second vacciantion of GRADASIL, the patient had recieved triamcinolicne acetonide injrction in the gluteal area, "another injection site", for the treatment of allergian. On 05-MAR-2008 the patient was vaccianted intramuscularly in theleft arm woth the second 0.5ml dose of GRADASIL (lot no. 655604/0052X). Concomitant therapy included drospirenous (+) ethinyl entradiol, loratadine and imphatamine espartate.amphetamineSO4/dex. On the same day, "almost immediately after her second immunization", the patient developed pain and muscle tissue atrophy at the injection site. On 01-AUG-2008, the patient was vaccinated witht he third dose of GRADASIL. As of 01-AUG-08, it was reportedthat the patient was recovering from the injection site pain. As of 08-SEP-2008, it was reported that muscle tissue athrophy at the injection site still persisted "five months later". The patient sought unspecified medical attention via office visist. Muscle tissue athrophy at the injection site was considered to be disabling and pther important medical event. Additional information is not expected.


VAERS ID: 336226 (history)  
Form: Version 1.0  
Age: 20.0  
Sex: Female  
Location: Texas  
Vaccinated:2007-11-28
Onset:2008-08-12
   Days after vaccination:258
Submitted: 2008-12-29
   Days after onset:139
Entered: 2008-12-29
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 1266U / 3 LA / IM

Administered by: Unknown       Purchased by: Unknown
Symptoms: Antiacetylcholine receptor antibody positive, Antinuclear antibody increased, Autoimmune disorder, Myasthenia gravis
SMQs:, Systemic lupus erythematosus (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 5 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: YAZ
Current Illness: NONE
Preexisting Conditions: Allergy to Penicillin PMH: oral contraception, TB 2005, ex-smoker, social drinker. Allergy: PCN, morphine. Family hx: high cholesterol; depression; Cushings syndrome.
Allergies:
Diagnostic Lab Data: ANA Panel results were higher then normal. I had a blood test for acetylcholine receptor antibodies. Normal is .05 and below. My results were 64.o. 5/13/09 hospital records received DOS 11/25/08 to 11/27/08. LABS and DIAGNOSTICS: CT lack of sulci small ventricles otherwise WNL. LP hazy, cell count 795 mm3 (H), neutrophils 76%, Gram stain (-) other than WBCs, protein 70 mg/dL (H). CBC WNL other than WBC 15000, Segs 90%. CHEM: sodium 132 mmol/L (L) otherwise WNL. 5/19/09 Received HSV titre (-) & MRI head (-). FARR DNA DS ab 21.6(H). ANA titer 1:320(+), speckled homogeneous. Abnormal PAP smear w/atypical squamous cells. WBC 28.6(H), segs 86%(H), lymphs 7%(L), ANC 25.7(H).CMP, hepatitis panel, CRP, RA factor, ASO all WNL. Acetylcholine binding ab 64(H). 5/19/09 Received HSV titre (-) & MRI head (-).
CDC Split Type:

Write-up: Diagnosed with Myasthenia Gravis (autoimmune disease) 5/13/09 hospital records received DOS 11/25/08 to 11/27/08. FINAL DIAGNOSIS: Myasthenia gravis, viral meningitis Post vaccination droopy left eyelid, difficulty running, weak grip, mouth and jaw fatigue, diplopia, dizziness. Admitted for IVIG treatment. Headache, increased ptosis, upper and lower extremity weakness. Nausea, vomiting 5/14/09 Received Neuro medical records of 11/24/2008. FINAL DX: myasthenia gravis Records reveal patient experienced weakness x 2 mo starting w/left eyelid droop, then mouth weakness, arm heaviness, grip strength decreased, leg stiffness, difficulty arising from sitting position, diplopia, intermittent left lazy eye, mouth/jaw fatigue, tiredness, slurred speech, DOE, heartburn, difficulty chewing & swallowing, loss of balance, loss of memory, urinary frequency esp at night. Sent to hospital for CT, IVIG x 2 days, steroids. 5/18/09 Received PCP medical records of 10/21/08-2/25/2009. Records reveal patient experienced fatigue, dizziness, blurred vision, gen weakness, difficulty concentrating & memory retention difficulties x approx 1 mo when seen 10/21. Referred to Rheum. No further visits until 2/25/09 s/p myasthenia gravis. 5/18/09 Received medical records from Rheum but was only labs of 11/19/2008.


VAERS ID: 340835 (history)  
Form: Version 1.0  
Age: 14.0  
Sex: Female  
Location: Texas  
Vaccinated:2007-09-24
Onset:2007-12-01
   Days after vaccination:68
Submitted: 2009-02-26
   Days after onset:453
Entered: 2009-02-27
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0245U / 1 LA / IM
MNQ: MENINGOCOCCAL CONJUGATE (MENACTRA) / SANOFI PASTEUR U2323AA / 1 RA / IM
TDAP: TDAP (BOOSTRIX) / GLAXOSMITHKLINE BIOLOGICALS AC52B016BA / 6 RA / IM

Administered by: Other       Purchased by: Other
Symptoms: Grand mal convulsion, Loss of consciousness, Neurological examination normal, Petit mal epilepsy
SMQs:, Torsade de pointes/QT prolongation (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Convulsions (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (narrow), Hypoglycaemia (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 4 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: None
Current Illness:
Preexisting Conditions: None HPV #2 given 12/6/07, Lot # 0928U, IM/RA; HPV #3 given 8/7/08, Lot # 1967U, IM/RA.
Allergies:
Diagnostic Lab Data: neurological, normal LABS: CBC, CMP, UA, BNP & urine drug screen all WNL. Prolactin28.27(H). Potassium 3.3 (L). CT head WNL except chronic sinusitis.
CDC Split Type: WAES0902USA03784

Write-up: Information has been received from a registered nurse concerning a 15 year old female patient with no pertinent medical history and no known drug allergies or reactions who on 24-SEP-2007 was vaccinated with the first 0.5 ml IM dose of GARDASIL. There was no concomitant medication. In December 2007, the patient experienced blackout episodes and petit mal seizures. On 06-DEC-2007 the patient was vaccinated with the second 0.5 ml IM dose of GARDASIL, and on 07-AUG-2008 the patient received the third GARDASIL. Some time in 2008, the patient experienced grand mal seizures and had been hospitalized multiple times (details of hospitalizations not provided). The patient had been subsequently evaluated by an unspecified neurologist who had prescribed an unspecified anti-seizure medication. Neurological tests were performed with normal results. At the time of this report, the patient''s blackout episodes, petit mal seizures and grand mal seizures persisted. Blackout episodes, petit mal seizures and grand mal seizures were also considered to be disabling and immediately life-threatening. This is one of several reports received from the same source. Additional information has been requested. 3/9/09 Received hospital records for multiple ER & admits: 3/20/2008 FINAL DX: syncopal episode vs anxiety attack Records reveal patient experienced brief episode of syncope while getting ready to travel to hospital for eye surgery she was very nervous about. Exam in ER revealed chewing movement of mouth/lips, shaking of LUE but was awake & alert. Tx w/anti anxiety med, improved & d/c to home. 4/20/2008 FINAL DX: syncope r/o seizure Records reveal patient experienced sudden LOC & fell to ground striking head. Out for approx 5 min w/jerking/seizure activity for short time. Exam in ER was WNL. Remained stable, d/c to home & referred to Neuro. 10/9/2008 Final DX: postictal state, probable seizure PTA; hypokalemia Records reveal patient experienced HA, facial redness & passed out. Remained stable, d/c to home w/PCP f/u. PMH: congenital heart disease w/open heart surgery, lazy eye w/eye surgery, petit mal seizures x approx 6 mo. 2/18-2/19/2009 FINAL DX: No d/c summary dictated. Neuro states recurrent petit mal seizure Records reveal patient admitted by Neuro s/p petit mal seizure activity while at school w/inattention & shaking of RUE. ER exam was WNL. Meds adjusted 2/24-2/25/2009 FINAL DX: no d/c summary dictated. Neuro states recurrent seizure activity, suspect to be petit mal in type, localized & partial. Exam revealed tonic clinic activity of LUE intermittently. Meds changed, d/c to home w/neuro f/u.


VAERS ID: 345220 (history)  
Form: Version 1.0  
Age: 15.0  
Sex: Female  
Location: Texas  
Vaccinated:2009-03-06
Onset:2009-03-06
   Days after vaccination:0
Submitted: 2009-04-14
   Days after onset:38
Entered: 2009-04-17
   Days after submission:3
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / IM

Administered by: Other       Purchased by: Other
Symptoms: Activities of daily living impaired, Dizziness
SMQs:, Anticholinergic syndrome (broad), Dementia (broad), Vestibular disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: Unknown
CDC Split Type: WAES0903USA02323

Write-up: Information has been received from a physician concerning a 15 year old female who on 06-MAR-2009 was vaccinated with GARDASIL IM 0.5ml. Concomitant therapy included a recent shot of DEPO-PROVERA. The patient experienced dizziness on 06-MAR-2007, 07-MAR-2009 and 09-MAR-2009. The physician did not say if there was any dizziness occurring on 08-MAR-2009. The patient "had to leave school". The patient sought unspecified medical attention. Dizziness was considered to be disabling. Additional information has been requested.


Result pages: 1 2 3 4   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?TABLE=ON&GROUP1=AGE&GROUP2=SEX&EVENTS=ON&VAX[]=HPV&VAX[]=HPV2&VAX[]=HPV4&DISABLE=Yes&STATE[]=TX


Copyright © 2019 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166